Register for free to listen to this article
Listen with Speechify
0:00
1:00
HAUPPAUGE, N.Y.— Eppendorf North America and Akonni Biosystems haveentered into a joint marketing agreement to promote Akonni TruTip nucleic acidextraction kits configured for use with Eppendorf epMotion automated pipettingsystems. Under the agreement, Eppendorf will promote the extraction kits toclinical, clinical research and forensic laboratories in North America. Akonniwill initially introduce two high-throughput TruTip extraction kits for use onthe epMotion systems: one for isolating influenza RNA from nasal swab andnasopharyngeal aspirate samples, and a second for extracting genomic DNA fromsaliva. Akonni plans to develop and supply additional kits for the EppendorfepMotion family of systems in the near future. 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue